These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 27851813)

  • 1. PLD-Specific Small-Molecule Inhibitors Decrease Tumor-Associated Macrophages and Neutrophils Infiltration in Breast Tumors and Lung and Liver Metastases.
    Henkels KM; Muppani NR; Gomez-Cambronero J
    PLoS One; 2016; 11(11):e0166553. PubMed ID: 27851813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospholipase D isoforms differentially regulate leukocyte responses to acute lung injury.
    Abdulnour RE; Howrylak JA; Tavares AH; Douda DN; Henkels KM; Miller TE; Fredenburgh LE; Baron RM; Gomez-Cambronero J; Levy BD
    J Leukoc Biol; 2018 May; 103(5):919-932. PubMed ID: 29437245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Phospholipase D Genetically and Pharmacologically for Studying Leukocyte Function.
    Gomez-Cambronero J; Ganesan R
    Methods Mol Biol; 2018; 1835():297-314. PubMed ID: 30109659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two sites of action for PLD2 inhibitors: The enzyme catalytic center and an allosteric, phosphoinositide biding pocket.
    Ganesan R; Mahankali M; Alter G; Gomez-Cambronero J
    Biochim Biophys Acta; 2015 Mar; 1851(3):261-72. PubMed ID: 25532944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipase D (PLD) drives cell invasion, tumor growth and metastasis in a human breast cancer xenograph model.
    Henkels KM; Boivin GP; Dudley ES; Berberich SJ; Gomez-Cambronero J
    Oncogene; 2013 Dec; 32(49):5551-62. PubMed ID: 23752189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The phospholipase D inhibitor FIPI potently blocks EGF-induced calcium signaling in human breast cancer cells.
    Stricker HM; Rommerswinkel N; Keil S; Gnoth SA; Niggemann B; Dittmar T
    Cell Commun Signal; 2021 Apr; 19(1):43. PubMed ID: 33832505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Yin/Yan of CCL2: a minor role in neutrophil anti-tumor activity in vitro but a major role on the outgrowth of metastatic breast cancer lesions in the lung in vivo.
    Lavender N; Yang J; Chen SC; Sai J; Johnson CA; Owens P; Ayers GD; Richmond A
    BMC Cancer; 2017 Jan; 17(1):88. PubMed ID: 28143493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Fluoro-2-indolyl des-chlorohalopemide (FIPI), a phospholipase D pharmacological inhibitor that alters cell spreading and inhibits chemotaxis.
    Su W; Yeku O; Olepu S; Genna A; Park JS; Ren H; Du G; Gelb MH; Morris AJ; Frohman MA
    Mol Pharmacol; 2009 Mar; 75(3):437-46. PubMed ID: 19064628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases.
    Tabariès S; Ouellet V; Hsu BE; Annis MG; Rose AA; Meunier L; Carmona E; Tam CE; Mes-Masson AM; Siegel PM
    Breast Cancer Res; 2015 Mar; 17(1):45. PubMed ID: 25882816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cationic polysaccharide spermine-pullulan drives tumor associated macrophage towards M1 phenotype to inhibit tumor progression.
    Xie L; Yang Y; Meng J; Wen T; Liu J; Xu H
    Int J Biol Macromol; 2019 Feb; 123():1012-1019. PubMed ID: 30439425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Insights for Drugs Developed for Phospholipase D Enzymes.
    Stieglitz KA
    Curr Drug Discov Technol; 2018; 15(2):81-93. PubMed ID: 28814238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-series Resolvins activate Phospholipase D in phagocytes during inflammation and resolution.
    Ganesan R; Henkels KM; Shah K; De La Rosa X; Libreros S; Cheemarla NR; Serhan CN; Gomez-Cambronero J
    FASEB J; 2020 Dec; 34(12):15888-15906. PubMed ID: 33047359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of phospholipases D1 and 2 in astroglial proliferation: effects of specific inhibitors and genetic deletion.
    Burkhardt U; Beyer S; Klein J
    Eur J Pharmacol; 2015 Aug; 761():398-404. PubMed ID: 25967349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipase D2 drives mortality in sepsis by inhibiting neutrophil extracellular trap formation and down-regulating CXCR2.
    Lee SK; Kim SD; Kook M; Lee HY; Ghim J; Choi Y; Zabel BA; Ryu SH; Bae YS
    J Exp Med; 2015 Aug; 212(9):1381-90. PubMed ID: 26282875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emodin suppresses pulmonary metastasis of breast cancer accompanied with decreased macrophage recruitment and M2 polarization in the lungs.
    Jia X; Yu F; Wang J; Iwanowycz S; Saaoud F; Wang Y; Hu J; Wang Q; Fan D
    Breast Cancer Res Treat; 2014 Nov; 148(2):291-302. PubMed ID: 25311112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospholipase D2 promotes disease progression of renal cell carcinoma through the induction of angiogenin.
    Kandori S; Kojima T; Matsuoka T; Yoshino T; Sugiyama A; Nakamura E; Shimazui T; Funakoshi Y; Kanaho Y; Nishiyama H
    Cancer Sci; 2018 Jun; 109(6):1865-1875. PubMed ID: 29660846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-Gingerol as an arginase inhibitor prevents urethane-induced lung carcinogenesis by reprogramming tumor supporting M2 macrophages to M1 phenotype.
    Yao J; Du Z; Li Z; Zhang S; Lin Y; Li H; Zhou L; Wang Y; Yan G; Wu X; Duan Y; Du G
    Food Funct; 2018 Sep; 9(9):4611-4620. PubMed ID: 30151521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholipase D inhibitors reduce human prostate cancer cell proliferation and colony formation.
    Noble AR; Maitland NJ; Berney DM; Rumsby MG
    Br J Cancer; 2018 Jan; 118(2):189-199. PubMed ID: 29136407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoregulation of phospholipase D activity is coupled to selective induction of phospholipase D1 expression to promote invasion of breast cancer cells.
    Kang DW; Park MH; Lee YJ; Kim HS; Lindsley CW; Alex Brown H; Min do S
    Int J Cancer; 2011 Feb; 128(4):805-16. PubMed ID: 20473892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Puerarin inhibits M2 polarization and metastasis of tumor-associated macrophages from NSCLC xenograft model via inactivating MEK/ERK 1/2 pathway.
    Kang H; Zhang J; Wang B; Liu M; Zhao J; Yang M; Li Y
    Int J Oncol; 2017 Feb; 50(2):545-554. PubMed ID: 28101568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.